Skip to Main Content

Paper Details

Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery.
NPJ Vaccines
2
2023
COVID-19, HBsAg, HBsAg core, HBsAgs, S2P, S6P, S6P-HBsAgs, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 monoclonal antibodies, SARS-CoV-2 spike, WA1, full-length S2P, mRNA-1273, mice, proline
Author NameAffiliation
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases
Cheng ChengVaccine Research Center, National Institute of Allergy and Infectious Diseases
Yaroslav TsybovskyVaccine Research Center Electron Microscopy Unit, Inc., Frederick National Laboratory for Cancer Research
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases
  • 1 - 6

Datasets

Release 1.2